Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Condition:   Poliomyelitis Interventions:   Biological: Experimental vaccine;   Biological: IPV control vaccine;   Biological: single-person sIPV control vaccine Sponsor:   Sinovac Biotech Co., Ltd Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials